Market Overview

Benzinga's Top #PreMarket Gainers

Related CYTX
Cytori Announces Senior Management Changes; Christopher Calhoun CEO and Director of Cytori Therapeutics, is Retiring as CEO of the Company, Effective Immediately
Cytori Receives IDE Approval from FDA to Initiate US Clinical Trial of Adipose-Derived Regenerative Cells in Hamstring Injuries
Related GTAT
These iPad Air 2 Concepts Are Awesome
Morning Market Losers

Cytori Therapeutics (NASDAQ: CYTX) surged 39.23% to $2.91 in the pre-market session after the company announced a partnership to commercialize Cytori Cell Therapy for the cardiovascular, renal and diabetes markets in China, Hong Kong, Malaysia, Singapore and Australia.

GT Advanced Technologies (NASDAQ: GTAT) shares jumped 21.48% to $10.18 in pre-market trading following Monday's announcement of deal with Apple for sapphire materials.

Endo Health Solutions (NASDAQ: ENDP) shares gained 21.45% to $53.00 in the pre-market session after the company announced its plans to acquire Paladin Labs for $1.6 billion in stock and cash.

Corinthian Colleges (NASDAQ: COCO) soared 6.48% to $2.30 in the pre-market trading after the company reported FQ1 results.

Posted-In: PreMarket GainersNews Pre-Market Outlook Markets Movers

 

Most Popular

Related Articles (COCO + CYTX)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free